ATE484752T1 - Verfahren zur unterscheidung zwischen ischämischem und hämorrhagischem schlaganfall - Google Patents

Verfahren zur unterscheidung zwischen ischämischem und hämorrhagischem schlaganfall

Info

Publication number
ATE484752T1
ATE484752T1 AT04768075T AT04768075T ATE484752T1 AT E484752 T1 ATE484752 T1 AT E484752T1 AT 04768075 T AT04768075 T AT 04768075T AT 04768075 T AT04768075 T AT 04768075T AT E484752 T1 ATE484752 T1 AT E484752T1
Authority
AT
Austria
Prior art keywords
ischemic
differentiation
hemorrhagic stroke
apo
subject
Prior art date
Application number
AT04768075T
Other languages
English (en)
Inventor
Pierre Lescuyer
Denis Francois Hochstrasser
Jean-Charles Sanchez
Laure Allard
Elisabeth Guillaume
Original Assignee
Electrophoretics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Electrophoretics Ltd filed Critical Electrophoretics Ltd
Application granted granted Critical
Publication of ATE484752T1 publication Critical patent/ATE484752T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4709Amyloid plaque core protein
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775Apolipopeptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121Serpins
    • G01N2333/8128Antithrombin III
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2871Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
AT04768075T 2003-08-15 2004-08-16 Verfahren zur unterscheidung zwischen ischämischem und hämorrhagischem schlaganfall ATE484752T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0319167A GB2404981A (en) 2003-08-15 2003-08-15 Diagnostic method for stroke
PCT/GB2004/003512 WO2005017523A2 (en) 2003-08-15 2004-08-16 Method for discriminating between ischemic and haemorrhagic stroke

Publications (1)

Publication Number Publication Date
ATE484752T1 true ATE484752T1 (de) 2010-10-15

Family

ID=28052545

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04768075T ATE484752T1 (de) 2003-08-15 2004-08-16 Verfahren zur unterscheidung zwischen ischämischem und hämorrhagischem schlaganfall

Country Status (10)

Country Link
US (1) US7767401B2 (de)
EP (1) EP1671130B1 (de)
JP (2) JP4949026B2 (de)
AT (1) ATE484752T1 (de)
AU (1) AU2004264560B2 (de)
CA (1) CA2535890C (de)
DE (1) DE602004029594D1 (de)
ES (1) ES2350164T3 (de)
GB (1) GB2404981A (de)
WO (1) WO2005017523A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002069A2 (en) 2005-06-21 2007-01-04 Anthony Goncalves Serum biomarkers for breast cancer
US9347945B2 (en) 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
EP3153860A3 (de) * 2005-12-22 2017-06-14 Abbott Molecular Inc. Verfahren und markerkombinationen zur untersuchung auf veranlagung von lungenkrebs
WO2007112055A2 (en) * 2006-03-23 2007-10-04 Breyer Emilta De Guzman Apolipoprotein fingerprinting technique
US20100086481A1 (en) * 2006-07-11 2010-04-08 Baird Alison E Differential expression of molecules associated with intra-cerebral hemorrhage
CA2735525A1 (en) * 2008-08-04 2010-02-11 The Board Of Regents Of The University Of Texas System Multiplexed diagnostic test for preterm labor
JP5747370B2 (ja) 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
US20100332254A1 (en) * 2009-06-26 2010-12-30 Michael Maschke In-vitro device support for x-ray based kidney function test
US20100331673A1 (en) * 2009-06-26 2010-12-30 Michael Maschke System and method for reducing patient risk of allergic reaction to contrast agents or medical material
BR112012011230A2 (pt) * 2009-11-13 2016-04-05 Bg Medicine Inc fatores de risco e previsão de infarto do miocárdio
US20120064558A1 (en) * 2010-09-13 2012-03-15 Lopez Mary Frances Assays for Differentiating between Ischemic and Hemorrhagic Stroke in a Human Patient
EP2791678A1 (de) * 2011-12-13 2014-10-22 Kieran Gerard Walshe Homogenes kompetitives lateralfluss-assay
PE20160533A1 (es) 2013-03-14 2016-06-09 Bayer Healthcare Llc Anticuerpos monoclonales contra antitrombina beta que forma complejos con heparina
KR20190039937A (ko) 2016-07-08 2019-04-16 스태튼 바이오테크놀로지 비.브이. 항-ApoC3 항체 및 이의 사용 방법
CA3059133A1 (en) 2017-04-21 2018-10-25 Staten Biotechnology B.V. Anti-apoc3 antibodies and methods of use thereof
US10538583B2 (en) 2017-10-31 2020-01-21 Staten Biotechnology B.V. Anti-APOC3 antibodies and compositions thereof
SG11202003980PA (en) 2017-10-31 2020-05-28 Staten Biotechnology B V Anti-apoc3 antibodies and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801531A (en) * 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5320945A (en) * 1989-07-14 1994-06-14 Boehringer Mannheim Gmbh Method and reagent for the determination of antithrombin III
US5538897A (en) * 1994-03-14 1996-07-23 University Of Washington Use of mass spectrometry fragmentation patterns of peptides to identify amino acid sequences in databases
US6107045A (en) * 1994-06-30 2000-08-22 Oklahoma Medical Research Foundation Antibodies to lipoproteins and apolipoproteins and methods of use thereof
JPH08178923A (ja) * 1994-12-21 1996-07-12 Cosmo Sogo Kenkyusho:Kk リポタンパク質又はアポリポタンパク質の免疫学的測定方法
US6429017B1 (en) * 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
CA2263063C (en) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
US20030165503A1 (en) * 2000-03-03 2003-09-04 Jean-Charles Fruchart Vaccine for the treatment of atherosclerosis
DE60127104D1 (de) * 2000-03-20 2007-04-19 Eastern Virginia Med School Prostatakrebs-marker
JP3561218B2 (ja) * 2000-08-10 2004-09-02 株式会社いかがく 動脈硬化性病変の診断用キット
JP2005522669A (ja) * 2001-08-20 2005-07-28 バイオサイト インコーポレイテッド 卒中および脳損傷の診断マーカーおよびその使用方法
GB0203768D0 (en) * 2002-02-18 2002-04-03 Univ Geneve Diagnostic method for stroke

Also Published As

Publication number Publication date
JP2011221037A (ja) 2011-11-04
US20070166758A1 (en) 2007-07-19
US7767401B2 (en) 2010-08-03
EP1671130A2 (de) 2006-06-21
AU2004264560A1 (en) 2005-02-24
EP1671130B1 (de) 2010-10-13
ES2350164T3 (es) 2011-01-19
GB2404981A (en) 2005-02-16
DE602004029594D1 (de) 2010-11-25
AU2004264560B2 (en) 2009-07-30
CA2535890C (en) 2015-05-05
JP4949026B2 (ja) 2012-06-06
JP2007502401A (ja) 2007-02-08
WO2005017523A2 (en) 2005-02-24
CA2535890A1 (en) 2005-02-24
GB0319167D0 (en) 2003-09-17
WO2005017523A3 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
ATE484752T1 (de) Verfahren zur unterscheidung zwischen ischämischem und hämorrhagischem schlaganfall
Kašička Recent advances in capillary electrophoresis and capillary electrochromatography of peptides
EP1364042A4 (de) Verfahren zur bestimmung der konzentration eines analyten in einem teststreifen
DK1644737T3 (da) Indretning og fremgangsmåde til simultan udförelse af blodgruppebestemmelse, serum-kontrapröve og anti-stofsögningstest
US20080264792A1 (en) Apparatus for Protein Separation Using Capillary Isoelectric Focusing-Hollow Fiber Flow Field Flow Fractionation and Method Thereof
DE59913233D1 (de) Verfahren und substanzen für die diagnose und therapie von sepsis und sepsisähnlichen systemischen infektionen
ATE394679T1 (de) Scd40l, papp-a und plazentaler-wachstumsfaktor (pigf) als biochemische markerkombinationen bei kardiovaskulären erkrankungen
DE60203560D1 (de) Verfahren und Vorrichtung für kontinuierliche Vorhersage, Überwachung und Regelung der Verdichterstabilität durch Bestimmung von Indikatoren für umlaufende Strömungsablösung und Pumpen
ATE440151T1 (de) Verfahren zur beurteilung eines krankheitzustandes mittels nachweis von partikel- und nicht partikelgebundenen nukleinsäuren in blutplasma und -serum
SG169395A1 (en) Detection of cancer by elevated levels of bcl-2
ATE540319T1 (de) Verfahren für die bestimmung von fk506
EP1681566A4 (de) Verfahren zur trennung und zum testen eines adiponectin-multimers
DE60117592D1 (de) Diagnose von pre-eclampsia
EP2287618A3 (de) Verfahren zur Diagnose neurodegenerativer Erkrankungen
WO2014195728A3 (en) Methods and compositions relating to neurodegenerative diseases
CA2510377A1 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
DE60129314D1 (de) Diagnose von leberfibrose mit hilfe von serummarkeralgorithmen
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
WO2006030232A3 (en) Monitoring of wounds by measurement of protease and protease inhibitor levels in wound fluids
DE10082504D2 (de) Indikatorpeptid zur Diagnose und/oder Vorhersage von cardiovasculären und /oder endothelialen Erkrankungen, Antikörperzusammensetzung und immunoassay
Annovazzi et al. Capillary electrophoresis with laser‐induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples
DE50103032D1 (de) Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 19-9
ATE475096T1 (de) Unterscheidung zwischen baktiereller meningitis und viraler meningitis
DE50313393D1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
EP2322646A8 (de) Verfahren zum Nachweis von Plättchenthrombose oder Organversagen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties